Second Hypertension Drug Recalled Due to Contamination
THURSDAY, Nov. 1, 2018 -- Another hypertension drug is being recalled due to contamination that could pose a cancer risk, the U.S. Food and Drug Administration says.
Certain lots of irbesartan are being recalled by SciGen because they contain an...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Avapro | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Hypertension | Pharmaceuticals